Saving money on the PBS: ranibizumab or bevacizumab for neovascular macular degeneration?
Where this comes from
- Record sourced from PubMed, PMID 21644867.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
The cost differential between these two drugs is no longer defensible.